A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 14, Issue 1 I, 1995, Pages 32-38

  Macdonald, P S ^a   Keogh, A M ^a   Marshman, D ^a   Richens, D ^a   Harvison, A ^a   Kaan , A M ^a   Spratt, P M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; OKT 3; PLACEBO; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GASTRITIS; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; VIRUS MYOCARDITIS; VIRUS PNEUMONIA; VIRUS REACTIVATION;

ACTUARIAL ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GANCICLOVIR; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 0028938767     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)